Tian-tian Zhu
Xinxiang, 453003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The Role of Ion Channels in Pulmonary Hypertension: A Review.
Journal: Pulmonary circulation
Published: April 22, 2024
Spermidine attenuates monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting purine metabolism and polyamine synthesis-associated vascular remodeling.
Journal: International immunopharmacology
Published: March 04, 2024
Sodium butyrate alleviates right ventricular hypertrophy in pulmonary arterial hypertension by inhibiting H19 and affecting the activation of let-7g-5p/IGF1 receptor/ERK.
Journal: European journal of pharmacology
Published: October 11, 2023
Hydroxy-Safflower Yellow A Mitigates Vascular Remodeling in Rat Pulmonary Arterial Hypertension.
Journal: Drug design, development and therapy
Published: October 09, 2023
A ring N(CH3)2-based derivative of resveratrol inhibits pulmonary vascular remodeling in hypoxia pulmonary hypertension.
Journal: European journal of pharmacology
Published: April 28, 2023
LncRNA H19 deficiency protects against the structural damage of glomerular endothelium in diabetic nephropathy via Akt/eNOS pathway.
Journal: Archives of physiology and biochemistry
Published: July 22, 2022
Tert-Butylhydroquinone alleviates insulin resistance and liver steatosis in diabetes.
Journal: Indian journal of pharmacology
Published: May 13, 2022
Plasma exosomes confer hypoxic pulmonary hypertension by transferring LOX-1 cargo to trigger phenotypic switching of pulmonary artery smooth muscle cells.
Journal: Biochemical pharmacology
Published: April 22, 2022
MicroRNA-137 Inhibited Hypoxia-Induced Proliferation of Pulmonary Artery Smooth Muscle Cells by Targeting Calpain-2.
Journal: BioMed research international
Published: July 01, 2021
Tertiary butylhydroquinone alleviated liver steatosis and increased cell survival via β-arrestin-2/PI3K/AKT pathway.
Journal: Iranian journal of basic medical sciences
Published: June 07, 2021
Aspirin ameliorates pulmonary vascular remodeling in pulmonary hypertension by dampening endothelial-to-mesenchymal transition.
Journal: European journal of pharmacology
Published: March 10, 2021
Last Updated: 09/26/2026